CEO of the Swiss TPH and President of the Scientific and Technical Advisory Committee (STAC) of the CRESIB
Professor Marcel Tanner obtained a doctorate in medical biology from the University of Basel and a masters in public health from the University of London. He is currently Director of the Swiss Tropical and Public Health Institute (formerly the Swiss Tropical Institute) and Professor of Epidemiology and Medical Parasitology at the University of Basel and the Federal Institute of Technology. Since 1977, his scientific work has ranged from basic research on the cell biology and immunology of malaria, schistosomiasis, tripanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning. His research, teaching and health planning expertise are based on his long experience working in rural and urban areas in Africa (mainly Tanzania, Chad, Burkina Faso and Côte d’Ivoire) and Asia (China, Thailand and Laos).
He was co-investigator and coordinator of the first African malaria vaccine trial in 1992 and has since participated in several major intervention trials related to malaria (iron supplementation, intermittent preventive treatment) and schistosomiasis. He has published over 500 original research papers and is the author of numerous book chapters and reviews.
He also acts as advisor in several areas (the prevention and control of communicable diseases and related research, strengthening health systems, and capacity building) in various national and international bodies as well as for boards and committees, including the World Health Organisation’s TDR Scientific and Technical Advisory Committee (STAC-TDR), Drugs for Neglected Diseases initiative (DNDi), the Child Health and Nutrition Research Initiative (CHNRI), and the INCLEN Trust. Professor Tanner is President of the Scientific and Technical Advisory Committee of the Barcelona Centre for International Health Research (CRESIB).